 |
3-Amino-N-[2-(dimethylamino)ethyl]naphthalimide; 5-Amino-2-[2-(dimethylamino)ethyl]-1H-benz[d,e]isoquinoline-1,3(2H)-dione |
069408-81-7 |
C16H17N3O2 |
 |
4′-Deoxydoxorubicin hydrochloride; [2S-[2alpha(8R*,10R*),4beta,6beta]]-10-[(4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione hydrochloride; (8S,10S)-10-[[(2S,4R,6S)-4-[ |
063950-06-1; 063521-85-7 (free base) |
C27H29NO10.ClH |
|
|
2,2-Dimethyl-5-(2,5-xylyloxy)valeric acid; 2,2-Dimethyl-5-(2,5-dimethylphenoxy)pentanoic acid |
025812-30-0 |
C15H22O3 |
|
|
7-Chloro-5-(2-chlorophenyl)-3-hydroxy-1-methyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one |
000848-75-9 |
C16H12Cl2N2O2 |
|
|
1-(2-Chlorophenyl)-2-tert-butylaminoethanol hydrochloride |
041570-61-0 (free base) |
C12H18ClNO.ClH |
|
|
all-trans-N-Ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenamide |
056281-36-8 |
C23H31NO2 |
|
|
5-Azacitidine; 4-Amino-1-(beta-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one; 1-(beta-D-Ribofuranosyl)-5-azacytosine |
000320-67-2 |
C8H12N4O5 |
|
|
2,6-Dimethyl-4-(3-nitrophenyl)-3-methoxycarbonyl-1,4-dihydropyridine-5-carboxylic acid 2-(N-benzyl-N-methylamino)ethyl ester hydrochloride; 2,6-Dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)]ethyl ester |
054527-84-3; 055985-32-5 (free base) |
C26H29N3O6.ClH |
|
|
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine maleate |
059467-94-6; 059467-70-8 (free base); 059467-96-8 |
C18H13ClFN3.C4H4O4 |
|
|
N-[1-[2-(4-Ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidinyl]-N-phenylpropanamide hydrochloride; N-[1-[2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl]-4-(methoxymethyl)-4-piperidyl]propionanilide hydrochloride |
069049-06-5; 071195-58-9 (free base); 070879-28-6 |
C21H32N6O3.ClH |
